457 related articles for article (PubMed ID: 22523509)
1. Drug-induced parkinsonism.
Shin HW; Chung SJ
J Clin Neurol; 2012 Mar; 8(1):15-21. PubMed ID: 22523509
[TBL] [Abstract][Full Text] [Related]
2. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
Munhoz RP; Bertucci Filho D; Teive HA
Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced parkinsonism in the elderly: incidence, management and prevention.
López-Sendón JL; Mena MA; de Yébenes JG
Drugs Aging; 2012 Feb; 29(2):105-18. PubMed ID: 22250585
[TBL] [Abstract][Full Text] [Related]
4. Acute dopamine receptor blockade in substantia nigra pars reticulata: a possible model for drug-induced Parkinsonism.
Cáceres-Chávez VA; Hernández-Martínez R; Pérez-Ortega J; Herrera-Valdez MA; Aceves JJ; Galarraga E; Bargas J
J Neurophysiol; 2018 Dec; 120(6):2922-2938. PubMed ID: 30256736
[TBL] [Abstract][Full Text] [Related]
5. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
[TBL] [Abstract][Full Text] [Related]
6. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
Oh YS; Kwon DY; Kim JS; Park MH; Berg D
Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425
[TBL] [Abstract][Full Text] [Related]
7. Shared functional neural substrates in Parkinson's disease and drug-induced parkinsonism: association with dopaminergic depletion.
Oh SW; Shin NY; Yoon U; Sin I; Lee SK
Sci Rep; 2020 Jul; 10(1):11617. PubMed ID: 32669608
[TBL] [Abstract][Full Text] [Related]
8. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
[TBL] [Abstract][Full Text] [Related]
9. Parkinsonism in the psychiatric setting: an update on clinical differentiation and management.
Powell A; Gallur L; Koopowitz L; Hayes MW
BMJ Neurol Open; 2020; 2(1):e000034. PubMed ID: 33681781
[TBL] [Abstract][Full Text] [Related]
10. Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [
Jaakkola E; Joutsa J; Mäkinen E; Noponen T; Pitkonen M; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V
J Neurol Sci; 2019 Sep; 404():124-127. PubMed ID: 31374410
[TBL] [Abstract][Full Text] [Related]
11. Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism.
Morley JF; Cheng G; Dubroff JG; Wood S; Wilkinson JR; Duda JE
Mov Disord Clin Pract; 2017; 4(4):603-606. PubMed ID: 30363414
[TBL] [Abstract][Full Text] [Related]
12. Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.
Feldman M; Marmol S; Margolesky J
Ther Clin Risk Manag; 2022; 18():1129-1142. PubMed ID: 36573102
[TBL] [Abstract][Full Text] [Related]
13. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
14.
Yang HJ; Park SH; Seo M; Weon YC; Kim Y
Neurotoxicology; 2018 Jan; 64():78-84. PubMed ID: 28259768
[TBL] [Abstract][Full Text] [Related]
15. The symptoms asymmetry of drug-induced parkinsonism is not related to nigrostriatal cell degeneration: a SPECT-DaTSCAN study.
Gajos A; Dąbrowski J; Bieńkiewicz M; Płachcińska A; Kuśmierek J; Bogucki A
Neurol Neurochir Pol; 2019; 53(4):311-314. PubMed ID: 31441498
[TBL] [Abstract][Full Text] [Related]
16. Combined use of ¹²³I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study.
Kim JS; Oh YS; Kim YI; Yang DW; Chung YA; You IeR; Lee KS
Arch Gerontol Geriatr; 2013; 56(1):124-8. PubMed ID: 22633343
[TBL] [Abstract][Full Text] [Related]
17. Substantia nigra micro-haemorrhage causing ipsilateral unilateral Parkinsonism and abnormal dopamine transporter scan uptake.
Ghoneim A; Pollard C; Tyagi A; Jampana R
BJR Case Rep; 2021 Feb; 7(1):20200118. PubMed ID: 33614119
[TBL] [Abstract][Full Text] [Related]
18. Drug-Induced Parkinsonism: Too Many Cooks in the Kitchen.
Liotta M; Bell H; Vu AT; Stillman M
Cureus; 2023 Sep; 15(9):e44896. PubMed ID: 37814773
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.
Ward KM; Citrome L
Neurol Ther; 2018 Dec; 7(2):233-248. PubMed ID: 30027457
[TBL] [Abstract][Full Text] [Related]
20. The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism.
Bovi T; Antonini A; Ottaviani S; Antonioli A; Cecchini MP; Di Francesco V; Bassetto MA; Zamboni M; Fiaschi A; Moretto G; Sbarbati A; Osculati F; Tinazzi M
J Neurol; 2010 Nov; 257(11):1882-9. PubMed ID: 20635186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
